Hideki Suganami
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Ophthalmology top 1%
- Glaucoma and retinal disorders
Papers in
-
- Peroxisome Proliferator-Activated Receptors 10
- Metabolism, Diabetes, and Cancer 5
-
- Diabetes Treatment and Management 19
- Co-authors
- Eiichi Araki (22 shared papers)Koutaro Yokote (21 shared papers)Shun Ishibashi (20 shared papers)Shizuya Yamashita (15 shared papers)Hidenori Arai (15 shared papers)Tetsuya Yamamoto (6 shared papers)Hidenobu Tanihara (6 shared papers)Yasuaki Kuwayama (5 shared papers)
- Journals
- Journal of Atherosclerosis and Thrombosis (12 papers)Diabetes Obesity and Metabolism (7 papers)Therapeutic Innovation & Regulatory Science (6 papers)Atherosclerosis Supplements (6 papers)Journal of Diabetes Investigation (5 papers)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Hideki Suganami
83 papers receiving 2.2k citations
Hideki Suganami's Hit Papers
Peers
Comparison fields: 5 of 107
- Endocrinology, Diabetes and Metabolism 644
- Ophthalmology 303
- Cardiology and Cardiovascular Medicine 242
- Epidemiology 343
- Surgery 432
Countries citing papers authored by Hideki Suganami
This map shows the geographic impact of Hideki Suganami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Suganami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Suganami more than expected).
Fields of papers citing papers by Hideki Suganami
This network shows the impact of papers produced by Hideki Suganami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Suganami. The network helps show where Hideki Suganami may publish in the future.
Co-authors
The 25 scholars most cited alongside Hideki Suganami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 171 | |
| 2 | 2016 | 160 | |
| 3 | 2017 | 150 | |
| 4 | Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator‐activated receptor α modulator (SPPARMα), versus placebo in patients with non‐alcoholic fatty liver disease Hit paper breakdown → | 2021 | 149 |
| 5 | 2018 | 128 | |
| 6 | 2018 | 112 | |
| 7 | 2015 | 106 | |
| 8 | 2015 | 105 | |
| 9 | 2014 | 104 | |
| 10 | 2017 | 102 | |
| 11 | 2014 | 73 | |
| 12 | 2000 | 66 | |
| 13 | 2019 | 65 | |
| 14 | 1995 | 45 | |
| 15 | 2018 | 42 | |
| 16 | 2019 | 40 | |
| 17 | 2019 | 37 | |
| 18 | 2015 | 37 | |
| 19 | 2018 | 34 | |
| 20 | 2021 | 32 |
About Hideki Suganami
Hideki Suganami is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery, Statistics and Probability and Ophthalmology, having authored 86 papers that have together received 2.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (19 papers), Lipoproteins and Cardiovascular Health (11 papers), Peroxisome Proliferator-Activated Receptors (10 papers), Statistical Methods in Clinical Trials (8 papers), Metabolism, Diabetes, and Cancer (5 papers), Glaucoma and retinal disorders (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cardiac electrophysiology and arrhythmias (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (644 citations), Ophthalmology (303 citations), Cardiology and Cardiovascular Medicine (242 citations), Epidemiology (343 citations) and Surgery (432 citations). Hideki Suganami has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Eiichi Araki, Koutaro Yokote, Shun Ishibashi, Shizuya Yamashita, Hidenori Arai, Tetsuya Yamamoto, Hidenobu Tanihara, Yasuaki Kuwayama, Makoto Araie and Toshihiro Inoue. Their work appears in journals such as Journal of Atherosclerosis and Thrombosis, Diabetes Obesity and Metabolism, Therapeutic Innovation & Regulatory Science, Atherosclerosis Supplements and Journal of Diabetes Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.